Search company, investor...
EndoGastric Solutions company logo

EndoGastric Solutions

Founded Year



Debt - IV | Alive

Total Raised


Last Raised

$18M | 6 mos ago

About EndoGastric Solutions

EndoGastric Solutions is developing an endoscopic medical device and procedure that can restore the competency of the anti-reflux barrier, which is distorted in GERD patients and contributes to acid reflux and regurgitation. Designed specifically for performing incisionless reconstructive gastrointestinal procedures, the device is introduced into the body through the mouth, rather than through an abdominal incision. The company was founded in 2002 and is based in Redmond, Washington.

Headquarters Location

18109 NE 76th Street Suite 100

Redmond, Washington, 98052,

United States


Missing: EndoGastric Solutions's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: EndoGastric Solutions's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing EndoGastric Solutions

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

EndoGastric Solutions is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,721 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

EndoGastric Solutions Patents

EndoGastric Solutions has filed 58 patents.

The 3 most popular patent topics include:

  • Digestive system
  • Esophagus disorders
  • Endoscopy
patents chart

Application Date

Grant Date


Related Topics




Esophagus disorders, Digestive system, Digestive system surgery, Endoscopy, Inflammations


Application Date


Grant Date



Related Topics

Esophagus disorders, Digestive system, Digestive system surgery, Endoscopy, Inflammations



Latest EndoGastric Solutions News

EndoGastric Solutions, Inc.® Expands Executive Leadership Team with Key Industry Veterans

Apr 17, 2023

REDMOND, Wash.--(BUSINESS WIRE)--EndoGastric Solutions, Inc.® (EGS) today announced the addition of two members to the executive leadership team. Brett Reynolds is appointed Chief Financial Officer, and Sarah Lyon joins as Vice President of Healthcare Economics, Reimbursement, and Policy. The addition of these executive team members will support the scale of the Company’s next growth and geographic expansion phase. “I am pleased to welcome Mr. Reynolds and Ms. Lyon to our executive team,” said

EndoGastric Solutions Frequently Asked Questions (FAQ)

  • When was EndoGastric Solutions founded?

    EndoGastric Solutions was founded in 2002.

  • Where is EndoGastric Solutions's headquarters?

    EndoGastric Solutions's headquarters is located at 18109 NE 76th Street, Redmond.

  • What is EndoGastric Solutions's latest funding round?

    EndoGastric Solutions's latest funding round is Debt - IV.

  • How much did EndoGastric Solutions raise?

    EndoGastric Solutions raised a total of $321.94M.

  • Who are the investors of EndoGastric Solutions?

    Investors of EndoGastric Solutions include Canaan Partners, SightLine Partners, Lightstone Ventures, BCG Digital Ventures, Advanced Technology Ventures and 14 more.

  • Who are EndoGastric Solutions's competitors?

    Competitors of EndoGastric Solutions include Ivenix, ValenTx, Uptake Medical, Torax Medical, CircuLite and 11 more.

Compare EndoGastric Solutions to Competitors


Satiety, Inc. is a medical device company focused on the development of less invasive devices for the treatment of obesity. Obesity is a global health problem, affecting 70 million people in the U.S. and 300 million worldwide, and growth of which is causing increases in obesity-related diseases such as diabetes, high blood pressure and cardiovascular disease. Obesity surgery has been shown to be the only long-term effective means of weight loss for morbidly obese patients. Satiety's first product, the TOGA System, enables physicians to perform a procedure similar to traditional restrictive obesity surgeries, but without surgical incisions. In this procedure, the TOGA System devices are inserted transorally (through the mouth) and are used to reduce the capacity of the stomach to give patients a feeling of fullness after a small meal. The procedure is intended to be safer and easier for patients to tolerate than conventional obesity surgery. Safety and effectiveness of the TOGA System are currently being evaluated in a multi-center U.S. Study and the system is not available for sale in the United States.


VytronUS is developing an integrated imaging and ablation platform for cardiac electrophysiologists. Harnessing the capability of ultrasound energy, the company's system creates a high resolution image of the interior of the heart for procedure planning and allows the physician to draw a desired treatment pattern on the image at the workstation.

NeoGraft Technologies

NeoGraft Technologies is developing Angioshield, an intraperative system that creates a micro-fibrous, polymer sleeve intimately surrounding the outside surface of a harvested vein to mechanically reinforce and protect it from overdilation.

Axial Biotech

Axial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five motion preserving, fusionless surgical devices (including such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Axial ( is located in Salt Lake City, Utah.

Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

Endothelix Logo

Endothelix, Inc. is a cardiovascular device company focused on addressing inaccurate individualized prediction of cardiovascular risk and inadequate monitoring of the vascular response to treatments.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.